Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCDNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCDNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCDNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.44.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.44.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.44.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.45.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.45.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.45.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FP.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.102NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.102NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.102NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCCNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used